Medtronic to announce financial results for its third quarter of fiscal year 2026

Rhea-AI Summary

Medtronic (NYSE: MDT) will report third-quarter fiscal 2026 results on Tuesday, February 17, 2026, covering the quarter ended January 23, 2026.

A news release with summary financial information will be issued at ~5:45 a.m. Central Standard Time, followed by a video webcast at 7:00 a.m. CST. Replay and transcript will be posted within 24 hours.

News Market Reaction – MDT

-0.34%

-0.34% Session close to close

In the Feb 11 session, MDT declined 0.34%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for Medtronic’s third-quarter fiscal 2026 results, including a ...

Analysis

This announcement sets the timetable for Medtronic’s third-quarter fiscal 2026 results, including a news release at 5:45 a.m. CST and a webcast at 7:00 a.m. CST on February 17, 2026. Context from the latest 10-Q shows net sales of $8,961 million and diluted EPS of $1.07, alongside strong cash generation. Investors may focus on updated revenue trends, earnings, cash flow, and pipeline progress when those detailed figures are released.

Key Figures

Quarterly net sales: $8,961 million Prior-year net sales: $8,403 million Quarterly net income: $1,374 million +5 more

8 metrics

Quarterly net sales $8,961 million Quarter ended October 24, 2025 (10-Q)

Prior-year net sales $8,403 million Quarter ended October 27, 2024 (10-Q comparison)

Quarterly net income $1,374 million Quarter ended October 24, 2025 (10-Q)

Diluted EPS $1.07 Quarter ended October 24, 2025 (vs $0.99 prior year)

Six-month net sales $17,539 million First six months of fiscal 2026 (10-Q)

Six-month net income $2,414 million First six months of fiscal 2026 (10-Q)

Operating cash flow $2,013 million First six months of fiscal 2026 (10-Q)

Dividends paid $1,820 million First six months of fiscal 2026 (10-Q)

Historical Context

5 past events · Latest: Feb 03 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 03	Acquisition intent	Positive	+0.5%	Announced intent to acquire CathWorks to expand interventional cardiology portfolio.
Feb 02	FDA, Medicare access	Positive	-0.2%	Medicare access and new FDA clearances expanding MiniMed 780G insulin delivery options.
Jan 23	CE Mark, IDE trial	Positive	-0.5%	CE Mark and first U.S. IDE cases for Affera Sphere-360 PFA catheter.
Jan 12	FDA 510(k) clearance	Positive	-0.6%	FDA clearance for MiniMed Go smart MDI system with Abbott Instinct sensor.
Jan 07	Clinical data update	Positive	-0.5%	Real-world data showing MiniMed 780G met ADA time-in-range goals on missed-bolus days.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent product and regulatory wins often saw mildly negative next-day moves, while the acquisition announcement drew a modest gain.

Recent Company History

Over the past months, Medtronic reported several positive catalysts, including an acquisition intent for CathWorks on Feb 3, 2026, which saw shares up 0.46%. Multiple diabetes-related FDA clearances and CE Mark milestones for Affera PFA technology, plus strong MiniMed 780G real-world data, all produced small share price declines (from -0.24% to -0.59%). Against this backdrop of constructive fundamentals but mixed price responses, today’s announcement simply schedules the release of third-quarter fiscal 2026 results rather than providing new financial figures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GALWAY, Ireland, Feb. 11, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, February 17, 2026, for its third quarter of fiscal year 2026, which ended on Friday, January 23, 2026.

• A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com
• A video webcast to discuss results will begin at 7:00 a.m. CST and can be accessed at https://investorrelations.medtronic.com
• Within 24 hours of the video webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Justin Paquette
Public Relations
+1-612-271-7935

Ingrid Goldberg 
Investor Relations 
+1-763-505-2696

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-to-announce-financial-results-for-its-third-quarter-of-fiscal-year-2026-302685523.html

SOURCE Medtronic plc

FAQ

When will Medtronic (MDT) release Q3 fiscal 2026 results and what time will the webcast start?

Medtronic will release Q3 fiscal 2026 results on February 17, 2026 and the webcast starts at 7:00 a.m. CST. According to Medtronic, a news release with summary financial information appears at about 5:45 a.m. CST before the webcast.

Where can investors find the Medtronic (MDT) Q3 2026 news release and webcast replay?

The news release will be available on Medtronic's news site and the webcast on its investor relations site. According to Medtronic, a replay and transcript will be posted within 24 hours under Events on investor relations.

What quarter does Medtronic's February 17, 2026 announcement cover for fiscal 2026?

The announcement covers Medtronic's third quarter of fiscal 2026, which ended on January 23, 2026. According to Medtronic, the results announced will reflect the period through that date.

Will Medtronic (MDT) provide a transcript of its Q3 fiscal 2026 prepared remarks?

Yes. A replay and transcript of the prepared remarks will be available within 24 hours after the video webcast. According to Medtronic, both items will be posted via the Events link on its investor relations site.

How can media or investors contact Medtronic regarding the Q3 fiscal 2026 announcement?

Medtronic provided dedicated contacts for media and investors for the Q3 announcement. According to Medtronic, Public Relations and Investor Relations phone contacts are listed for follow-up questions ahead of the webcast.